Jul 24, 2026
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.30 to $8.96.
The split itself did not change the total investment value.
Trinity Biotech plc (NASDAQ:TRIB) operates in the Medical specialties industry.
Trinity Biotech plc company overviewTrinity Biotech plc's most recent stock split was on July 24, 2026. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
Trinity Biotech plc (NASDAQ:TRIB) has split its stock 3 times: a 1-for-4 reverse split on June 2, 2005, a 1-for-5 reverse split on February 23, 2024, and a 1-for-30 reverse split on July 24, 2026.
Trinity Biotech plc has split its stock 3 times. This history records 3 reverse splits between June 2, 2005 and July 24, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Trinity Biotech plc's 1-for-30 reverse split on July 24, 2026, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Trinity Biotech plc has not announced a new split in our records. Its most recent split was on July 24, 2026, less than a year ago. Companies announce splits in advance, and any new NASDAQ:TRIB split will appear on this page.
Already premium?